![Biomensio Oy](https://tesi.fi/wp-content/uploads/2021/01/biomensio_logo-200x44.png)
Portfolio
Venture Bridge
Venture Bridge
Industry
Deep tech
Deep tech
Investment Year
2021
2021
Biomensio is developing a bioanalysis-based Diagnostics-as-a-Service Platform. In the future, Biomensio’s digital reader can be used e.g. in traffic patrolling and for workplace drug testing, food safety measures, and anti-doping tests in sports.